The Legal 500 > Kluge Advokatfirma DA > Oslo, NORWAY > Press Releases > Kluge advises Wintershall in major swap transaction on the Norwegian Continental Shelf (NCS)

Kluge Advokatfirma DA

STØPERIGATA 1, PO BOX 1548 VIKA, 0117 OSLO, NORWAY

Tel:: Work +47 23 11 00 00

Web:: www.kluge.no
Email:

Stavanger, Oslo, Bergen

Kluge advises Wintershall in major swap transaction on the Norwegian Continental Shelf (NCS)

October 2012

Wintershall and Statoil announced Monday the 22.th of October a transaction whereby Wintershall will acquire interests in the Brage (32,7%), Gjøa (15%) and Vega (30%) fields. As compensation Wintershall will transfer a 15 % interest in the Edvard Grieg field to Statoil in addition to paying a cash consideration of USD 1,35 billion. An additional payment of up to USD 100 million will be paid contingent on the successful future development of the Vega field. Further, it is the joint intention of the parties that Wintershall takes over the operatorship of Brage. This is one of the largest licence transaction on the NCS.

Kluge has assisted Wintershall with a team lead by partners Thomas Abrahamsen and Olav Hasaas.

- “The fact that Wintershall trusted Kluge as legal advisor in this transaction shows Kluge’s leading position in advising on oil and gas transactions” says Managing Partner Snorre Haukali.

Kluge has in the recent years advised in a number of large licence transaction on the NCS. In 2011, Kluge advised Centrica in connection with the purchase of a number of licence interests from Statoil for an aggregated consideration of USD 1,625 billion.

Please refer to Wintershall’s press release for further information about this transaction; http://www.wintershall.com/en/press/detail/news/basf-subsidiary-wintershall-and-statoil-agree-on-asset-swap.html

For more information please visit www.kluge.no

Search News and Articles

Legal Developments by:
Kluge Advokatfirma DA

Norway not included when short sale regulations in EU take effect 1 November 2012

From 1 November 2012 EU Regulation 236/2012 on short selling and certain aspects of credit default swaps will come into effect. Although the Regulation is within the scope of the EEA Agreement, Norway has not implemented the EU Regulation. Based on unofficial information from the Norwegian authorities, we expect the implementation process to be delayed until at least late 2013. Meanwhile, existing rules on short sale in Norway will continue to apply for transactions performed on the Norwegian market.

- Kluge Advokatfirma DA

Legal Developments in Norway

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to

Bing Hodneland's contribution to "The Technology, Media and Telecommunications Review"

Bing Hodneland partners Olav Torvund, Jon Wessel-Aas and Magnus Ødegaard to present the Norwegian legal technology, media and telecommunication situation.

- Bing Hodneland advokatselskap DA
Norway not included when short sale regulations in EU take effect 1 November 2012

From 1 November 2012 EU Regulation 236/2012 on short selling and certain aspects of credit default swaps will come into effect. Although the Regulation is within the scope of the EEA Agreement, Norway has not implemented the EU Regulation. Based on unofficial information from the Norwegian authorities, we expect the implementation process to be delayed until at least late 2013. Meanwhile, existing rules on short sale in Norway will continue to apply for transactions performed on the Norwegian market.

- Kluge Advokatfirma DA
Proposed ban on personal import of medicinal products ordered via Internet

The Ministry of Health and Care has recently issued a hearing letter proposing stringent restrictions on import of medicinal products for personal use. Among the actions proposed, is a general ban on the import of prescription drugs, and access for Customs to seize and destroy falsified or illegal medicinal products.

- Advokatfirmaet Grette DA
Increased transparency for applications for marketing authorisation

On 17th July 2012, the Norwegian Medicines Agency (NMA) announced a change in their practice regarding disclosure of information for applications of marketing authorisations for medicinal products.

- Advokatfirmaet Grette DA
New Patent Office Act to enter into effect on 1st January 2013

A new Act on the Patent Office and Industrial Property Rights Appeals Commission (the Patent Office Act) will be enacted and come into effect on 1st January 2013. The current Act on the Industrial Property Protection Board was enacted in 1910, and time for a complete reform had come.

- Advokatfirmaet Grette DA
Sunset clause for medicinal products in Norway

"Sunset clause" is a common term for the provision which could lead to the cessation of the validity of the marketing authorisation of a medicinal product.

- Advokatfirmaet Grette DA
New review on pension schemes

Questions on pensions have long had a large political focus in Norway, in connection with pension reforms such as obligatory occupational pension and changes in the National Insurance Scheme.

- Advokatfirmaet Grette DA
New provisions on competition clauses

In 2011 it was expected that new provisions for competition clauses, customer clauses and non-recruitment clauses would come into force. As early as June 2010, the Department of Employment sent a proposal on new provisions in the Working Environment Act for comments.

- Advokatfirmaet Grette DA
Norway implements the EU block exemption regulation for R&D agreements

Earlier this year, EU Commission Regulation No 1217/2010 was implemented in Norwegian law.

- Advokatfirmaet Grette DA
Hearing: Reimbursement of off-label use of medicinal products

In accordance with the provisions of the Act on Medicines and the appurtenant Regulation on Medicinal Products, pre-approved reimbursement for use of a medicinal product outside the approved indications of the marketing authorization is not allowed.

- Advokatfirmaet Grette DA